	Testosterone-Sparing Treatment Strategies for Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Curr Oncol Rep Najdawi F, Sayyid RK, Ahlering T, Lee DI, Dobbs RW, Shahait M. PMID: 41915319 [PubMed - indexed for MEDLINE]
	The role of apoptotic genetic polymorphisms in prostate cancer susceptibility in a North West Spain population. Mol Genet Genomics López-Trigo N, Caeiro B, Pérez-Pérez J, Rodríguez-Alonso A, Aguín N, Rodríguez JA, Luis JR. PMID: 41915239 [PubMed - indexed for MEDLINE]
	[Early detection of prostate cancer-recommendations of the updated S3Â guideline 2025]. Urologie Al-Monajjed R, Albers P, Franiel T, Kötter T, Kristiansen G, Herrmann K, Wiegel T. PMID: 41915026 [PubMed - as supplied by publisher]
	Anti-Inflammatory Diet Index (AIDI) and Bladder Cancer Risk by Stage: A 22-Year Prospective Swedish Cohort Study (1998-2020). Cancer Epidemiol Biomarkers Prev Prado S, Ugge H, Vikerfors A, Fall K, Taj T. PMID: 41914981 [PubMed - as supplied by publisher]
	PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving (177)Lu-PSMA-617. Radiology Ghodsi A, Owens L, Demirci RA, Gafita A, Cheng HH, Hawley JE, Raychaudhuri R, Khan H, Sunkara R, Hsieh AC, Grivas P, Montgomery B, Yezefski TA, Nelson PS, Yu EY, Schweizer MT, Chen DL, Gulati R, Iravani A. PMID: 41914866 [PubMed - indexed for MEDLINE]
	PD-1/PD-L1 for prostate cancer: from clinical trials to practice. Expert Rev Clin Pharmacol Holmes A, Okobi T, Arham AB, Vaishampayan N, Subramanya D, Tagawa ST. PMID: 41914824 [PubMed - as supplied by publisher]
	Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer. Arch Ital Urol Androl Ferreira AM, Jarimba R, Rego A, Gama J, Almeida R, Eliseu M, Quaresma V, Nunes P, Sousa V, Figueiredo A. PMID: 41914231 [PubMed - indexed for MEDLINE]
	Perineal versus retropubic radical prostatectomy in localized prostate cancer: extended analysis of a prospective randomized cohort. Arch Ital Urol Androl Can U, Goktas C, Coskun A, Eryildirim B. PMID: 41914230 [PubMed - indexed for MEDLINE]
	Mechanosynthesis and computational studies of new imidazole-based selenium adducts as potential anticancer agents against human prostate and cervical cancer. Future Med Chem Abbas G, Bokhari TH, Iqbal MA, Rehman S, Ali A. PMID: 41914157 [PubMed - as supplied by publisher]
	Penile Cancer-A Preventable Cause of Death in Elderly Men. Br J Hosp Med (Lond) Uppal E, Kravvas G, Alnajjar H, Muneer A, Bunker C. PMID: 41914004 [PubMed - indexed for MEDLINE]
	An exceptional case illustrating the malignant transformation of metanephric adenoma. Indian J Pathol Microbiol Jagdale R, Jain S, Kochikar M. PMID: 41913421 [PubMed - indexed for MEDLINE]
	Elevated intravesical pressure promotes circulating tumor cell release in an orthotopic mouse model of bladder cancer. In Vitro Cell Dev Biol Anim Yi L, Chen Q, Zeng M, Xiao Z, Chen H, Song L, Zhu X. PMID: 41912978 [PubMed - as supplied by publisher]
	[WOLVERINE, aÂ meta-analysis on stereotactic radiotherapy of oligometastases in prostate cancer]. Strahlenther Onkol Dunst J. PMID: 41912926 [PubMed - as supplied by publisher]
	Tislelizumab combined with gemcitabine plus cisplatin for muscle-invasive upper tract urothelial carcinoma: A retrospective single-center cohort analysis. J Int Med Res Zhang J, Xiao Y, Cai D, Zhu H, Zhong W. PMID: 41912237 [PubMed - indexed for MEDLINE]
	Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment. J Natl Compr Canc Netw Su ZT, Florissi IS, Geller AE, Johnson Iii BA, Hoffman-Censits JH, Patel SH, Townsend JP, Hahn NM, Kates MR. PMID: 41911914 [PubMed - as supplied by publisher]
	EPR26-181: Racial and Ethnic Demographic Reporting in Studies Cited by the NCCN Testicular Cancer Guidelines: An Evidence Audit. J Natl Compr Canc Netw Sapkota S, Vemula SSM, Shah N, Motkur S, Bowen A, Sanka S, Kaur R, Bommanaveni A, Alshaikhli A, Isaac D. PMID: 41911765 [PubMed - in process]
	CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis. J Natl Compr Canc Netw Zhou S, Desai D, Benjamin S, Tsao CK. PMID: 41911734 [PubMed - in process]
	HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Vemula SSM, Kamal F, Fernet L, Afridi S, Shah N, Faheem MSB, Gergis S, Isaac D. PMID: 41911710 [PubMed - in process]
	Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability. JCO Precis Oncol Moussa MJ, Andreev-Drakhlin AY, Venkatesan AM, Matin SF, Xiao L, Tidwell RSS, Shah AY, Adriazola AC, Shaw L, Gao J, Lin JK, Goswami S, Msaouel P, Guo CC, Tannir NM, Siefker-Radtke AO, Alhalabi O, Campbell MT. PMID: 41911516 [PubMed - indexed for MEDLINE]
	Development of Machine Learning Models for Predicting Prostate Cancer in Biopsy Candidates Using Prostate-Specific Antigen, Magnetic Resonance Imaging, and Hematologic Parameters. Prostate Özlü DN, Ar, Emir B, Ayten A, Sungur U, Ek, Polat H, Karada, Bitkin A. PMID: 41911495 [PubMed - as supplied by publisher]

Articles 1 - 20 / 177169

Page 1 of 8859



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy